company background image
4121

Rossmax International TPEX:4121 Stock Report

Last Price

NT$21.50

Market Cap

NT$1.8b

7D

-4.9%

1Y

4.9%

Updated

25 Sep, 2022

Data

Company Financials
4121 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

4121 Stock Overview

Rossmax International Ltd. engages in the development and supply of healthcare products and solutions in Taiwan.

Rossmax International Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Rossmax International
Historical stock prices
Current Share PriceNT$21.50
52 Week HighNT$34.45
52 Week LowNT$18.30
Beta0.64
1 Month Change-9.85%
3 Month Change2.38%
1 Year Change4.88%
3 Year Change67.97%
5 Year Change79.92%
Change since IPO-11.73%

Recent News & Updates

Shareholder Returns

4121TW Medical EquipmentTW Market
7D-4.9%-3.2%-3.1%
1Y4.9%-8.9%-17.6%

Return vs Industry: 4121 exceeded the TW Medical Equipment industry which returned -8.9% over the past year.

Return vs Market: 4121 exceeded the TW Market which returned -17.6% over the past year.

Price Volatility

Is 4121's price volatile compared to industry and market?
4121 volatility
4121 Average Weekly Movement5.6%
Medical Equipment Industry Average Movement5.5%
Market Average Movement5.0%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 4121 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 4121's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988n/aChih-Ping Liuhttps://www.rossmax.com

Rossmax International Ltd. engages in the development and supply of healthcare products and solutions in Taiwan. The company offers activity monitor, a device for monitoring and tracking fitness-related metrics, such as distance walked or run, counting steps, and calories burned; body fat monitors that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact telephoto thermometers; and blood glucose monitoring system, a medical device for determining the approximate concentration of glucose in the blood. It also provides nebulizer, a drug delivery device used to administer medication; suction unit, a machine used to remove mucus and other bodily fluids; aero spacer, a device used to increase the ease of administering aerosolized medication; peak flow meter, a device used to monitor a person's ability to breathe out air; heating pad for therapy; and anti-decubitus mattresses.

Rossmax International Fundamentals Summary

How do Rossmax International's earnings and revenue compare to its market cap?
4121 fundamental statistics
Market CapNT$1.83b
Earnings (TTM)NT$118.56m
Revenue (TTM)NT$4.17b

15.4x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4121 income statement (TTM)
RevenueNT$4.17b
Cost of RevenueNT$2.78b
Gross ProfitNT$1.39b
Other ExpensesNT$1.28b
EarningsNT$118.56m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.40
Gross Margin33.42%
Net Profit Margin2.84%
Debt/Equity Ratio16.4%

How did 4121 perform over the long term?

See historical performance and comparison

Dividends

5.1%

Current Dividend Yield

78%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 4121 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4121?

Other financial metrics that can be useful for relative valuation.

4121 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.6x
Enterprise Value/EBITDA9.4x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 4121's PE Ratio compare to its peers?

4121 PE Ratio vs Peers
The above table shows the PE ratio for 4121 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average24.8x
4138 Dynamic Medical Technologies
12.9xn/aNT$1.7b
4106 Apex Medical
20.9xn/aNT$2.5b
6797 Taiwan Advanced Nanotech
3.4xn/aNT$2.1b
4161 Bioptik Technology Incorporation
62xn/aNT$1.2b
4121 Rossmax International
15.4xn/aNT$1.8b

Price-To-Earnings vs Peers: 4121 is good value based on its Price-To-Earnings Ratio (15.4x) compared to the peer average (24.8x).


Price to Earnings Ratio vs Industry

How does 4121's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

Price-To-Earnings vs Industry: 4121 is good value based on its Price-To-Earnings Ratio (15.4x) compared to the TW Medical Equipment industry average (20.5x)


Price to Earnings Ratio vs Fair Ratio

What is 4121's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4121 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4121's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 4121 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4121 (NT$21.5) is trading below our estimate of fair value (NT$23.13)

Significantly Below Fair Value: 4121 is trading below fair value, but not by a significant amount.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Rossmax International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


1.8%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rossmax International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether Rossmax International is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has Rossmax International performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


34.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4121 has high quality earnings.

Growing Profit Margin: 4121's current net profit margins (2.8%) are lower than last year (4.6%).


Past Earnings Growth Analysis

Earnings Trend: 4121's earnings have grown significantly by 34.1% per year over the past 5 years.

Accelerating Growth: 4121's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4121 had negative earnings growth (-35.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (19%).


Return on Equity

High ROE: 4121's Return on Equity (8.8%) is considered low.


Discover strong past performing companies

Financial Health

How is Rossmax International's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4121's short term assets (NT$2.4B) exceed its short term liabilities (NT$1.4B).

Long Term Liabilities: 4121's short term assets (NT$2.4B) exceed its long term liabilities (NT$934.7M).


Debt to Equity History and Analysis

Debt Level: 4121 has more cash than its total debt.

Reducing Debt: 4121's debt to equity ratio has reduced from 24.4% to 16.4% over the past 5 years.

Debt Coverage: 4121's debt is well covered by operating cash flow (151.7%).

Interest Coverage: 4121's interest payments on its debt are well covered by EBIT (11.4x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Rossmax International current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


5.12%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 4121's dividend (5.12%) is higher than the bottom 25% of dividend payers in the TW market (2.46%).

High Dividend: 4121's dividend (5.12%) is low compared to the top 25% of dividend payers in the TW market (6.73%).


Stability and Growth of Payments

Stable Dividend: 4121 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 4121's dividend payments have increased, but the company has only paid a dividend for 9 years.


Earnings Payout to Shareholders

Earnings Coverage: At its current payout ratio (78.4%), 4121's payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (29%), 4121's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average board tenure


CEO

Chih-Ping Liu

no data

Tenure

Mr. Chih-Ping Liu serves as Chairman and General Manager of Rossmax International Ltd. and has been its Director since December 13, 1988. Mr. Liu serves as Chairman of ROSSMAX medical electronics Shanghai...


Board Members

Experienced Board: 4121's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 1 shareholders own 0.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.63%
Mackenzie Financial Corporation
537,000NT$11.5m0%no data

Company Information

Rossmax International Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Rossmax International Ltd.
  • Ticker: 4121
  • Exchange: TPEX
  • Founded: 1988
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: NT$1.826b
  • Shares outstanding: 84.93m
  • Website: https://www.rossmax.com

Location

  • Rossmax International Ltd.
  • No. 189, Kang Chien Road
  • 12th Floor
  • Taipei
  • 114
  • Taiwan


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
4121TPEX (Taipei Exchange)YesCommon StockTWTWDJul 2003

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/25 00:00
End of Day Share Price2022/09/23 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.